Back to top
more

ShockWave Medical (SWAV)

(Delayed Data from NSDQ)

$330.13 USD

330.13
1,025,697

-0.75 (-0.23%)

Updated May 17, 2024 04:00 PM ET

After-Market: $330.09 -0.04 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 249)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.

Centene (CNC) Invests Nearly $8M to Build Texas Community Center

by Zacks Equity Research

Centene (CNC) collaborates with CHDI to establish a new community center in Texas, reflecting efforts to expand its Managed Care business across the state.

Why Is Shockwave Medical (SWAV) Down 8.3% Since Last Earnings Report?

by Zacks Equity Research

Shockwave Medical (SWAV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.

Should Invesco S&P MidCap 400 Pure Growth ETF (RFG) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for RFG

Here's Why You Should Retain Hologic (HOLX) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Hologic (HOLX) on the back of its continued strength in the Breast Health arm.

Catalent (CTLT) Expands Facility Capabilities in Shanghai

by Zacks Equity Research

Catalent's (CTLT) latest capability expansion is expected to boost its business in the clinical trials space in its Asia-Pacific Clinical Supply Services network.

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XHE

Masimo (MASI) Announces Positive Study Results on PBM by SpHb

by Zacks Equity Research

Masimo's (MASI) SpHb is likely to enhance transfusion management and post-operative patient outcomes on patients.

Merit Medical (MMSI) Hits 52-Week High: What's Driving It?

by Zacks Equity Research

Investors are optimistic about Merit Medical's (MMSI) slew of product launches.

Cooper Companies (COO) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal fourth-quarter results are likely to reflect segmental strength.

Henry Schein's (HSIC) New Tie-Up to Improve Patient Outcome

by Zacks Equity Research

Henry Schein's (HSIC) recent deal with VideaHealth is expected to aid dentists in proving greater transparency to patients, thus making better treatment recommendations and improving case acceptance.

Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for IWM

Boston Scientific's (BSX) New Buyout to Expand its Portfolio

by Zacks Equity Research

Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

by Zacks Equity Research

Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

by Zacks Equity Research

PerkinElmer (PKI) continues to gain from solid product portfolio despite forex woes.

Here's Why You Should Hold OPKO Health (OPK) Stock For Now

by Zacks Equity Research

OPKO Health (OPK) is likely to gain from the potential in RAYALDEE that targets a growing market coupled with new collaborations and acquisitions.

Merit Medical (MMSI) Launches New Inflation Device basixALPHA

by Zacks Equity Research

Merit Medical (MMSI) launches basixALPHA inflation device in the United States for one-handed preparation and fast inflation with minimal exertion to streamline angioplasty procedures.

The Zacks Analyst Blog Highlights ShockWave Medical, iRadimed and Tactile Systems Technology

by Zacks Equity Research

ShockWave Medical, iRadimed and Tactile Systems Technology are part of the Zacks top Analyst Blog.

Factors That Make Elevance Health (ELV) a Lucrative Bet Now

by Zacks Equity Research

Elevance Health (ELV) continues to benefit from sustained top-line growth, higher membership in Government business and a sturdy financial position.

AmerisourceBergen (ABC) Hits 52-Week High: What's Driving It?

by Zacks Equity Research

Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.

Boston Scientific (BSX) Posts Positive Post-Market Study Data

by Zacks Equity Research

The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.

Indrajit Bandyopadhyay headshot

3 Medical Instruments Stocks With Potential to Outperform

by Indrajit Bandyopadhyay

Here we discuss ShockWave Medical (SWAV), iRadimed (IRMD) and Tactile Systems Technology (TCMD), which have the potential to outperform their industry going forward.

QIAGEN's (QGEN) New Monkeypox Test to Aid Faster Identification

by Zacks Equity Research

QIAGEN's (QGEN) latest multiplex test is expected to strengthen its portfolio and boost its fight against the global monkeypox outbreak.

Here's Why You Should Retain Stryker (SYK) Stock For Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.